mash and semaglutide in with F2-F3 fibrosis: a holistic perspective on the ESSENCE phase 3 trial Exciting Phase 3 Data from

$150-$300 TIRZEPATIDE Tirzepatide, also known for Mounjaro and Zepbound, is a glucose-dependent insulinotropic polypeptide and human-based GLP-1 receptor agonist

Regular Monitoring Guidelines Regular check-ups are essential during your semaglutide treatment

Continuous glucose monitoring (CGM) systems, when available, provide comprehensive data about glucose trends and variability

Increased demand for GLP-1RAs for treating non-diabetic obesity has also driven increased off-label prescription (prescription of a drug by a physician to treat something it is not FDA approved for) of GLP-1RAs formulated to treat T2DM [18]

A careful evaluation and individual management are needed

Furthermore, in T2DM patients treated with GLP-1RAs, the increase in CTX may, at least in part, be attributed to the resumption of active osteoclastic activity, which had previously been suppressed by high glucose levels and the accumulation of advanced glycation end-products (AGEs) [1, 3]